LQ23
LQ23 is a selective inhibitor for CDC2-like kinase 2 (CLK2) with an IC50 of 1.4 nM. LQ23 exhibits anti-inflammatory activity[1].
Product Specifications
CAS Number
2997615-62-8
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lq23.html
Solubility
10 mM in DMSO
Smiles
N[C@H](COC1=CC(C2=CC=C(C3=C2)NN=C3C#CC4=CSC=C4)=CN=C1)CC(C)C
Molecular Formula
C24H24N4OS
Molecular Weight
416.54
References & Citations
[1]Sun Y, Hu T, Zhang M, Song J, Qin Z, Liu M, Ji J, Li Z, Qiu Z, Bian J. Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis. J Med Chem. 2024 Mar 28;67 (6) :4603-4623.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RPU56610-01 50 µg
Recombinant Human Low Density Lipoprotein Receptor Related Protein 1 (LRP1)
Sign In for Pricing
View Details RPU56610-02 100 µg
Recombinant Human Low Density Lipoprotein Receptor Related Protein 1 (LRP1)
Sign In for Pricing
View Details RPU56610-03 1 mg
Recombinant Human Low Density Lipoprotein Receptor Related Protein 1 (LRP1)
Sign In for Pricing
View Details 